Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Bempedoic Acid / Ezetimibe Combination Pill Study

World News: . []

ANN ARBOR Mich Aug 27 2018 GLOBE NEWSWIRE -- Esperion LINK  ESPR today announced positive LINK  results from the pivotal Phase 3 LINK  acid ezetimibe combination pill study 1002-053 This trial was a randomized double-blind parall...

More news and information about Esperion Therapeutics, Inc.

Published By:

Globe Newswire: 12:00 GMT Monday 27th August 2018

Published: .

Search for other references to "esperion" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us